Ep. 24 Trials and Tribulations: Part II of the Neuwave Story with Dr. Dan van der Weide and Dr. Fred Lee episode artwork

EPISODE · Apr 28, 2022 · 1H 17M

Ep. 24 Trials and Tribulations: Part II of the Neuwave Story with Dr. Dan van der Weide and Dr. Fred Lee

from BackTable Industry · host BackTable

We talk with electrical engineering professor Dr. Dan van der Weide and interventional radiologist Dr. Fred Lee about the lessons they learned in the early stages of founding their microwave ablation device company, including challenges with early teams and equity. --- EARN CME Reflect on how this Podcast applies to your day-to-day and earn AMA PRA Category 1 CMEs: https://earnc.me/OOv0RX --- SHOW NOTES In this episode, our host Dr. Bryan Hartley interviews electrical engineering professor Dr. Dan van der Weide and interventional radiologist Dr. Fred Lee about the lessons they learned in the early stages of founding their microwave ablation device company, including challenges with early teams and equity. This is the second installment of a three-part series about the origin, rise, and acquisition of NeuWave. The founders start by discussing the nature of their successful partnership and how each of them brought complementary perspectives to the company. On one hand, Dr. Lee has clinical experience that informs him about current medical devices and their limitations. Conversely, Dr. van der Weide has a broad-based understanding of energy and how it can be applied to medicine. Even after the acquisition of NeuWave, the two founders have continued to innovate and start subsequent new companies together. While the founders shared a common vision, they had early NeuWave experiences which taught them about team conflict. They share a salient lesson learned from hiring team members based on prior social connections instead of objective skill sets. Dr. Van der Weide warns against taking mental shortcuts and making assumptions about a person’s abilities, without first examining their experience in the startup world. He also gives advice on equity apportionment, saying that vesting schedules should be based on clear milestones, instead of a pre-set percentage. Finally, we discuss NeuWave’s early venture capital funding and the importance of choosing an investor that understands the vision and is willing to dedicate their honest effort to helping when obstacles arise. Stay tuned for the third installment! --- RESOURCES Elucent Medical: https://elucentmedical.com/ NeuWave Microablation System: https://www.jnjmedtech.com/en-US/product-family/neuwave-microwave-ablation-systems Wisconsin Alumni Research Foundation (WARF): https://www.warf.org/ Venture Investors: https://ventureinvestors.com/

Episode metadata supplied by the publisher feed · Published Apr 28, 2022

Embed this episode

NOW PLAYING

Ep. 24 Trials and Tribulations: Part II of the Neuwave Story with Dr. Dan van der Weide and Dr. Fred Lee

0:00 1:17:46

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BackTable Industry?

This episode is 1 hour and 17 minutes long.

When was this BackTable Industry episode published?

This episode was published on April 28, 2022.

Can I download this BackTable Industry episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!